Cite
APA Citation
Zhu, H., Zhang, C., Yang, X., & Yi, C. (2019). treatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma. Medicine, 98(10), . http://access.bl.uk/ark:/81055/vdc_100081058242.0x000021